Description
Albumin Solution for Infusions 10% 100 ml Vial
Composition:
Albumin (albumin) solution for infusions 10% contains albumin as the active ingredient.
Mechanism of Action:
Albumin is a vital protein that contributes to maintaining colloid osmotic pressure and regulating fluid balance in the body.
Pharmacological Properties:
Albumin solution for infusions 10% aids in the treatment of hypovolemia, hypoalbuminemia, burns, and acts as a plasma volume expander.
Indications for Use:
This solution is indicated for managing conditions such as hypovolemia, hypoalbuminemia, burns, and as a plasma volume expander in patients.
Contraindications:
Avoid using this solution in patients with known hypersensitivity to albumin or any components of the product. Caution is advised in patients with heart failure or renal impairment.
Side Effects:
Common side effects may include fluid overload or hypersensitivity reactions. Monitor patients closely during infusion for any adverse reactions.
Usage Instructions:
Administer the solution intravenously at the prescribed rate as determined by a healthcare professional based on individual patient requirements.
Benefits Compared to Analogues:
Albumin solution for infusions 10% offers effective restoration of plasma volume and enhanced hemodynamic stability in patients with hypovolemia, demonstrating its superiority over alternative treatments.
Suitable Patient Groups:
This solution is suitable for a wide range of patient populations, including children, adults, and the elderly, under appropriate medical supervision.
Storage and Shelf Life:
Store the solution as per the manufacturer’s instructions. Check the expiration date on the packaging and do not use expired products.
Packaging Description:
The product is available in a 100 ml vial containing 10% albumin solution for infusions.
Clinical Evidence and Proven Effectiveness:
Clinical studies have demonstrated the efficacy of albumin replacement therapy in managing hypovolemia and hypoalbuminemia. Research in the Journal of Critical Care emphasizes the positive impact of albumin on outcomes in critically ill patients.
